PD Dr. med. Federico Moriconi

Formazione professionale

Attività clinica

2005 – 2012Assistente medico, dipartimento di Gastroenterologia ed Endocrinologia, Ospedale universitario di Göttingen, Germania.
07/2011Specializzazione tedesca in Medicina Interna
07/2012-08/2014 Capo clinica, dipartimento di Gastroenterologia e Endocrinologia, Ospedale universitario di Göttingen, Germania.
01/2014 Specializzazione tedesca in Gastroenterologia
09/2014-08/2015Capo clinica, Dipartimento di Gastroenterologia ed Epatologia, Ospedale universitario di Basilea, Svizzera.
01/2015 Riconoscimento Diploma di laurea in Medicina e chirurgia dalla Confederazione svizzera.
01/2015Riconoscimento specializzazione in Medicina interna dalla Confederazione svizzera.
01/2015Riconoscimento specializzazione in Gastroenterologia dalla Confederazione svizzera.
09/2015-12/2015Capo clinica, Gastroenterologia, Ospedale regionale Emmental AG, Burgdorf, Svizzera.
01/2016-12/2017Capo clinica, Dipartimento di Gastroenterologia ed Epatologia, Stadtspital Triemli, Zurigo, Svizzera.
07/2017Autorizzazione a libero esercizio come medico nel Cantone Ticino
02/2018Rilascio numero di concordato (Nr. RCC: G260421).
Dal 02/2018Attività come Gastroenterologo accreditato presso lo studio medico GastroCentro in via Trevano 38, Lugano e presso la Clinica Luganese di Moncucco in via Moncucco 10, Lugano.
Dal 24.09.2018Responsabile studio medico GastroCentro Locarno
(Partner: Dr.ssa med. Helen Schaufelberger, Dr. med. Sandro Mossi)
federico moriconi medico

Attività scientifica

2003-2004Tesi sperimentale nei Laboratori del Dipartimento di Gastroenterologia ed Endocrinologia dell’Ospedale universitario di Göttingen, Germania.
2004-2005Borsa di studio di ricerca DAAD (Deutscher akademischer Austauschdienst) nei Laboratori del Dipartimento di Gastroenterologia ed Endocrinologia dell’Ospedale universitario di Göttingen (Germania).
2014Abilitazione alla libera docenza (Privat Dozent) per la specialità di Medicina interna presso l’Università Georg-August di Göttingen, Germania.
2017Abilitazione alla libera docenza (Privat Dozent) per la specialità di Gastroenterologia ed Epatologia presso l’Università di Zurigo, Svizzera.
2017Abilitazione nazionale italiana come Professore associato per il settore concorsuale 06/D4 (Malattie cutanee, malattie infettive e malattie dell’apparato digerente), MIUR (Ministero dell’istruzione, dell’università e della ricerca), Italia.


1Modulation of Chemokine- and Adhesion-Molecule Gene Expression and Recruitment of Neutrophil Granulocytes in Rat and Mouse Liver after a Single Gadolinium Chloride or Zymosan Treatment.
Ahmad S, Ramadori G, Moriconi F.
Int J Mol Sci. 2018 Dec 5;19(12). pii: E3891. doi: 10.3390/ijms19123891.
2Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease Patients.
Kaymak T, Moriconi F, Niess JH, Beglinger C, Hruz P.
Inflamm Intest Dis. 2018 Mar;2(3):171-179. doi: 10.1159/000486676. Epub 2018 Feb 21.
3Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.
Ramadori G, Bosio P, Moriconi F, Malik IA.
BMC Cancer. 2018 Mar 6;18(1):257. doi: 10.1186/s12885-018-4175-2.
4Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy.
Amanzada A, Goralczyk AD, Reinhardt L, Moriconi F, Cameron S, Mihm S.
BMC Infect Dis. 2014 Sep 17;14:503. doi: 10.1186/1471-2334-14-503.
5Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.
Khan S, Cameron S, Blaschke M, Moriconi F, Naz N, Amanzada A, Ramadori G, Malik IA.
World J Gastroenterol. 2014 Mar 21;20(11):2979-94. doi: 10.3748/wjg.v20.i11.2979.
6Regulation of iron uptake in primary culture rat hepatocytes: the role of acute-phase cytokines.
Ahmad S, Sultan S, Naz N, Ahmad G, Alwahsh SM, Cameron S, Moriconi F, Ramadori G, Malik IA.
Shock. 2014 Apr;41(4):337-45. doi: 10.1097/SHK.0000000000000107.
7Induction of chemokines and cytokines before neutrophils and macrophage recruitment in different regions of rat liver after TAA administration.
Amanzada A, Moriconi F, Mansuroglu T, Cameron S, Ramadori G, Malik IA.
Lab Invest. 2014 Feb;94(2):235-47. doi: 10.1038/labinvest.2013.134. Epub 2013 Nov 25.
8Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection.
Amanzada A, Goralczyk AD, Moriconi F, van Thiel DH, Ramadori G, Mihm S.
J Med Virol. 2013 Sep;85(9):1534-41. doi: 10.1002/jmv.23632.
9Rat model of fractionated (2 Gy/day) 60 Gy irradiation of the liver: long-term effects.
Rave-Fränk M, Malik IA, Christiansen H, Naz N, Sultan S, Amanzada A, Blaschke M, Cameron S, Ahmad S, Hess CF, Ramadori G, Moriconi F.
Radiat Environ Biophys. 2013 Aug;52(3):321-38. doi: 10.1007/s00411-013-0468-7. Epub 2013 Apr 18.
10Ferritin L and Ferritin H are differentially located within hepatic and extra hepatic organs under physiological and acute phase conditions.
Ahmad S, Moriconi F, Naz N, Sultan S, Sheikh N, Ramadori G, Malik IA.
Int J Clin Exp Pathol. 2013;6(4):622-9. Epub 2013 Mar 15.
11Identification of CD68(+) neutrophil granulocytes in in vitro model of acute inflammation and inflammatory bowel disease.
Amanzada A, Malik IA, Blaschke M, Khan S, Rahman H, Ramadori G, Moriconi F.
Int J Clin Exp Pathol. 2013;6(4):561-70. Epub 2013 Mar 15.
12Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein.
Naz N, Moriconi F, Ahmad S, Amanzada A, Khan S, Mihm S, Ramadori G, Malik IA.
Shock. 2013 Jun;39(6):520-6. doi: 10.1097/SHK.0b013e31829266b9.
13Differential regulation of ferritin subunits and iron transport proteins: an effect of targeted hepatic X-irradiation.
Naz N, Ahmad S, Cameron S, Moriconi F, Rave-Fränk M, Christiansen H, Hess CF, Ramadori G, Malik IA.
Biomed Res Int. 2013;2013:353106. doi: 10.1155/2013/353106. Epub 2013 Dec 12.
14Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma development.
Moriconi F, Ramadori P, Schultze FC, Blaschke M, Amanzada A, Khan S, Ramadori G.
Histochem Cell Biol. 2013 Mar;139(3):473-85. doi: 10.1007/s00418-012-1037-x. Epub 2012 Oct 4.
15Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1.
Amanzada A, Schneider S, Moriconi F, Lindhorst A, Suermann T, van Thiel DH, Mihm S, Ramadori G.
J Med Virol. 2012 Aug;84(8):1208-16. doi: 10.1002/jmv.23323.
16The anti-TNF-α antibody infliximab indirectly regulates PECAM-1 gene expression in two models of in vitro blood cell activation.
Moriconi F, Malik IA, Amanzada A, Blaschke M, Raddatz D, Khan S, Ramadori G.
Lab Invest. 2012 Feb;92(2):166-77. doi: 10.1038/labinvest.2011.160. Epub 2011 Oct 31.
17Ultra-rapid virological response, young age, low γ-GT/ALT-ratio, and absence of steatosis identify a subgroup of HCV Genotype 3 patients who achieve SVR with IFN-α(2a) monotherapy.
Amanzada A, Goralczyk A, Moriconi F, Blaschke M, Schaefer IM, van Thiel D, Mihm S, Ramadori G.
Dig Dis Sci. 2011 Nov;56(11):3296-304. doi: 10.1007/s10620-011-1933-2. Epub 2011 Oct 13.
18In regard to "Radiation-induced liver fibrosis is mitigated by gene therapy inhibiting transforming growth factor-β signalling in the rat" by Shi-Suo Du et al. (Int J Radiat Oncol Biol Phys 2010;78:1513-1523).
Christiansen H, Moriconi F, Rave-Fränk M, Malik IA, Hess CF, Ramadori G.
Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):960; author reply 960-1. doi: 10.1016/j.ijrobp.2011.01.072. No abstract available.
19Comparison of changes in gene expression of transferrin receptor-1 and other iron-regulatory proteins in rat liver and brain during acute-phase response.
Malik IA, Naz N, Sheikh N, Khan S, Moriconi F, Blaschke M, Ramadori G.
Cell Tissue Res. 2011 May;344(2):299-312. doi: 10.1007/s00441-011-1152-3. Epub 2011 Mar 26.
20Changes in gene expression of DOR and other thyroid hormone receptors in rat liver during acute-phase response.
Malik IA, Baumgartner BG, Naz N, Sheikh N, Moriconi F, Ramadori G.
Cell Tissue Res. 2010 Nov;342(2):261-72. doi: 10.1007/s00441-010-1067-4. Epub 2010 Oct 15.
21Single-dose gamma-irradiation induces up-regulation of chemokine gene expression and recruitment of granulocytes into the portal area but not into other regions of rat hepatic tissue.
Malik IA, Moriconi F, Sheikh N, Naz N, Khan S, Dudas J, Mansuroglu T, Hess CF, Rave-Fränk M, Christiansen H, Ramadori G.
Am J Pathol. 2010 Apr;176(4):1801-15. doi: 10.2353/ajpath.2010.090505. Epub 2010 Feb 25.
22Phagocytosis of gadolinium chloride or zymosan induces simultaneous upregulation of hepcidin- and downregulation of hemojuvelin- and Fpn-1-gene expression in murine liver.
Moriconi F, Ahmad G, Ramadori P, Malik I, Sheikh N, Merli M, Riggio O, Dudas J, Ramadori G.
Lab Invest. 2009 Nov;89(11):1252-60. doi: 10.1038/labinvest.2009.92. Epub 2009 Aug 31.
23Effect of irradiation on gene expression of rat liver adhesion molecules: in vivo and in vitro studies.
Moriconi F, Malik I, Ahmad G, Dudas J, Rave-Fränk M, Vorwerk H, Hille A, Hess CF, Ramadori G, Christiansen H.
Strahlenther Onkol. 2009 Jul;185(7):460-8. doi: 10.1007/s00066-009-1964-1. Epub 2009 Aug 28.
24Altered regulation of Prox1-gene-expression in liver tumors.
Dudas J, Mansuroglu T, Moriconi F, Haller F, Wilting J, Lorf T, Füzesi L, Ramadori G.
BMC Cancer. 2008 Apr 9;8:92. doi: 10.1186/1471-2407-8-92.
25Immune cells in primary gastrointestinal stromal tumors.
Cameron S, Haller F, Dudas J, Moriconi F, Gunawan B, Armbrust T, Langer C, Füzesi L, Ramadori G.
Eur J Gastroenterol Hepatol. 2008 Apr;20(4):327-34. doi: 10.1097/MEG.0b013e3282f3a403.
26Effect of radiation on gene expression of rat liver chemokines: in vivo and in vitro studies.
Moriconi F, Christiansen H, Raddatz D, Dudas J, Hermann RM, Rave-Fränk M, Sheikh N, Saile B, Hess CF, Ramadori G.
Radiat Res. 2008 Feb;169(2):162-9. doi: 10.1667/RR1006.1.
27Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F, Raddatz D, Ho NA, Yeruva S, Dudas J, Ramadori G.
Transl Res. 2007 Oct;150(4):223-32. Epub 2007 May 11.

Richiedi Appuntamento